By year 5, the DFS rates were 59% (95% CI: 57%, 61%) for ccRCC, 60% (95% CI: 54%, 66%) for pRCC, 81% (95% CI: 74%, 86%) for chRCC, and 33% (95% CI: 26%, 40%) for sRCC. The gene discussed is PRCC; the disease is nonpapillary renal cell carcinoma.